Like TP53, PTEN is frequently mutated in animal neoplasms, and a loss of PTEN upregulates the PI3K-AKT-mTOR pathway, facilitating cell cycle progression and increasing proliferation and anabolic metabolism throughout enhancing protein synthesis in cancer cells [104]. Here, AKT1 is linked to cancer.